Healthfacts - Media hype the new findings for Evista as an anti-breast cancer drug
Friday, December 5th, 2008Initial results from a government-sponsored study indicate that the osteoporosis drug raloxifene (brand name: Evista) may protect against breast cancer. The study compared it against an older anti-breast cancer drug, tamoxifen (…
